
New Delhi, 7 June 2021
As per news report of The Indian Express, Amphotericin-B is a pivotal antifungal drug used in mucormycosis treatment. Officials have pegged the adverse reactions to a change in the formation of the drug being supplied to medical colleges and hospitals. The first instance was recorded on Saturday evening in Bundelkhand Medical College (BMC) of Sagar district where 25 patients of the 42 that are being treated for mycormucosis began vomiting, developed mild fever and shivering, soon after they were administered Amphotericin-B. The state has reported a total of 1,056 active mucormycosis cases so far.
Source -indianexpress.com
If you like the story and if you wish more such stories, support our effort Make a donation.

Mon Jun 07 2021 | By Newsdesk

Mon Jun 07 2021 | By Newsdesk

Mon Jun 07 2021 | By Newsdesk


Mon Jun 07 2021 | By Newsdesk